Kevin F Mclaughlin Vericel Corp (VCEL) insider trading activity

Kevin F Mclaughlin is of Vericel Corp. Currently has a direct ownership of 15,100 shares of VCEL, which is worth approximately $655,340. The most recent transaction as insider was on May 07, 2025, when has been sold 7,000 shares (Common Stock) at a price of $39.98 per share, resulting in proceeds of $279,860. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K

26.89% 3M change

26.89% 12M change

Total Value Held $655,340

KEVIN F MCLAUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2025	SELL Open market or private sale	$279,860 $39.98 p/Share	7,000 Reduced 31.67%	15,100 Common Stock
May 07 2025	BUY Exercise of conversion of derivative security	$19,320 $2.76 p/Share	7,000 Added 24.05%	22,100 Common Stock
Apr 30 2025	BUY Exercise of conversion of derivative security	-	3,200 Added 17.49%	15,100 Common Stock
Feb 12 2025	SELL Open market or private sale	$388,150 $55.45 p/Share	7,000 Reduced 37.04%	11,900 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	$22,750 $3.25 p/Share	7,000 Added 35.18%	12,900 Common Stock
Nov 13 2024	SELL Open market or private sale	$388,780 $55.54 p/Share	7,000 Reduced 37.04%	11,900 Common Stock
Nov 13 2024	BUY Exercise of conversion of derivative security	$26,180 $3.74 p/Share	7,000 Added 27.03%	18,900 Common Stock
Aug 07 2024	SELL Open market or private sale	$321,720 $45.96 p/Share	7,000 Reduced 37.04%	11,900 Common Stock
Aug 07 2024	BUY Exercise of conversion of derivative security	$26,180 $3.74 p/Share	7,000 Added 33.49%	13,900 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	3,200 Added 21.19%	11,900 Common Stock
Apr 27 2023	BUY Exercise of conversion of derivative security	-	2,600 Added 23.01%	8,700 Common Stock
Apr 27 2022	BUY Exercise of conversion of derivative security	-	2,600 Added 29.89%	6,100 Common Stock
Apr 28 2021	BUY Exercise of conversion of derivative security	-	1,750 Added 33.33%	3,500 Common Stock

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

XLRN

ACCELERON PHARMA INC Healthcare

SVP, CFO and Treasurer

ADGI

Adagio Therapeutics, Inc. Healthcare

KFM